Literature DB >> 3295739

Pimozide treatment of tic and Tourette disorders.

A K Shapiro, E Shapiro, G Fulop.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295739

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  5 in total

1.  Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

Authors:  Shunmoogum A Patten; Dina Aggad; Jose Martinez; Elsa Tremblay; Janet Petrillo; Gary Ab Armstrong; Alexandre La Fontaine; Claudia Maios; Meijiang Liao; Sorana Ciura; Xiao-Yan Wen; Victor Rafuse; Justin Ichida; Lorne Zinman; Jean-Pierre Julien; Edor Kabashi; Richard Robitaille; Lawrence Korngut; J Alexander Parker; Pierre Drapeau
Journal:  JCI Insight       Date:  2017-11-16

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.

Authors:  Silvia Pozzi; Sai Sampath Thammisetty; Jean-Pierre Julien
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 5.  Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome.

Authors:  Julio Quezada; Keith A Coffman
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.